NeuroThera® Efficacy and Safety Trial - 3 (NEST-3): a double-blind, randomized, sham-controlled, parallel group, multicenter, pivotal study to assess the safety and efficacy of transcranial laser therapy with the NeuroThera® laser system for the treatment of acute ischemic stroke within 24 h of stroke onset:

Rationale Transcranial laser therapy is undergoing clinical trials in patients with acute ischemic stroke. The NeuroThera® Efficacy and Safety Trial-1 was stron...

Bibliographic Details

Main Authors:	Zivin, Justin A. (Author) , Sehra, R. (Author) , Shoshoo, A. (Author) , Albers, G. W. (Author) , Bornstein, N. M. (Author) , Dahlof, B. (Author) , Kasner, S. E. (Author) , Howard, G. (Author) , Shuaib, A. (Author) , Streeter, J. (Author) , Richieri, S. P. (Author) , Hacke, Werner (Author)
Format:	Article (Journal)
Language:	English
Published:	2014
In:	International journal of stroke Year: 2012, Volume: 9, Pages: 950-955
ISSN:	1747-4949
Online Access:	Verlag, lizenzpflichtig, Volltext: https://journals.sagepub.com/doi/10.1111/j.1747-4949.2012.00896.x
Author Notes:	J.A. Zivin, R. Sehra, A. Shoshoo, G.W. Albers, N.M. Bornstein, B. Dahlof, S.E. Kasner, G. Howard, A. Shuaib, J. Streeter, S.P. Richieri, and W. Hacke, for the NEST-3 investigators